Primary myelofibrosis

What changed: Primary myelofibrosis

Cancer page →

Every dated change on the records linked to Primary myelofibrosis, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Approval7Milestone8This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-17This recordPrimary myelofibrosis
Facts on this page last checked
When this page itself was last checked or edited.

2024 · 1

2024ApprovalMomelotinib
Momelotinib approved in EU
Myelofibrosis with moderate-to-severe anaemia

2023 · 2

2022 · 2

2021 · 1

2021ApprovalFedratinib
Fedratinib approved in EU
Myelofibrosis, JAK-inhibitor-naive or after ruxolitinib

2019 · 2

2018 · 1

2018MilestonePrimary myelofibrosis
MIPSS70 adds mutations to risk scoring for transplant decisions
A milestone in how this cancer is treated.

2013 · 1

2013MilestonePrimary myelofibrosis
CALR mutations found in most JAK2-negative myelofibrosis
A milestone in how this cancer is treated.

2012 · 1

2012ApprovalRuxolitinib
Ruxolitinib approved in EU
Myelofibrosis

2011 · 2

2005 · 1

2005MilestoneJAK2
JAK2 V617F discovered in most polycythaemia vera and half of myelofibrosis
A milestone in how this cancer is treated.

1879 · 1

1879MilestonePrimary myelofibrosis
Heuck describes myelofibrosis
A milestone in how this cancer is treated.